JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
about
STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.Mitogen-activated protein kinase signaling pathway in oral cancer.GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
P2860
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@en
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@nl
type
label
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@en
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@nl
prefLabel
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@en
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@nl
P2093
P2860
P356
P1433
P1476
JNK1/2 expression and modulation of STAT3 signaling in oral cancer.
@en
P2093
Alexandra Sklavounou
George Rassidakis
Ioannis Gkouveris
Maria Karanikou
Nikolaos Nikitakis
P2860
P304
P356
10.3892/OL.2016.4614
P577
2016-05-24T00:00:00Z